Specialties: corporate strategy, mergers and acquisitions, corporate development, business development, licensing, partnerships, sales and marketing, distributor management, negotiations, relationship management, contracting, contract negotiation, due diligence, strategic planning, launch planning, decision analysis, post merger integration, long range planning, corporate finance, management consulting, strategy consulting, organizational design, compensation, incentive plans, sales force effectiveness, emerging markets, U.S., US, europe, EU, Asia, Africa, biotech, pharma, biotechnology, healthcare

Senior Director, Strategy and Business Development @ From May 2015 to Present (8 months) Greater Los Angeles AreaDirector, Business Development - Asia @ Led business development activities in Asia including acquisitions, product licenses and strategic partnerships. Completed transactions include multi-year commercial partnerships in Hong Kong, Singapore and Malaysia. From July 2014 to May 2015 (11 months) Director, Commercial and Business Development - Europe, Turkey, Russia, Middle East and Africa @ Completed transactions include 428 million CHF acquisition of Neupogen® and Neulasta® rights from Roche in 100 markets and $700 million acquisition of MN Pharma, a private branded generics company in Turkey. In parallel, Regional General Manager with direct P&L responsibility for seven countries including South Africa, Israel and Serbia. Delivered in-the-market sales of $65 million with over 200% growth. From January 2012 to July 2014 (2 years 7 months) Director, Strategy and Corporate Development @ Led complex corporate strategy projects including emerging market expansion, China entry strategy, impact of US healthcare reform and review of transformational M&A opportunities. Completed transactions include $1.16 billion acquisition of Micromet, a public U.S. listed biotechnology company focused in oncology/hematology and $100 million divestiture of three marketed products to Swedish Orphan Biovitrum, a public pharmaceutical company focused on orphan diseases. From October 2008 to January 2012 (3 years 4 months) Senior Manager, Finance @ Prepared company-wide revenue and expense projections for senior leadership team, managed team of analysts providing finance and decision support to multiple US Business Units and led efficiency initiatives across Finance organization. From July 2003 to October 2008 (5 years 4 months) Senior Project Manager @ Managed cross functional project teams focused on company-wide initiatives including post merger integration and strategic planning. From June 2001 to July 2003 (2 years 2 months) Management Consultant @ Delivered client engagements focused on strategic planning, organizational design and sales force compensation and effectiveness. From October 1997 to June 2001 (3 years 9 months)

MBA, Finance and Organization Behavior @ Loyola Marymount UniversityBS, Business @ St. Mary's College of California